Publication:
MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

dc.contributor.authorCairoli, Victoria
dc.contributor.authorValle-Millares, Daniel
dc.contributor.authorTerrón-Orellana, Maria Carmen
dc.contributor.authorLuque, Daniel
dc.contributor.authorRyan, Pablo
dc.contributor.authorDomínguez, Lourdes
dc.contributor.authorMartín-Carbonero, Luz
dc.contributor.authorde Los Santos, Ignacio
dc.contributor.authorDe Matteo, Elena
dc.contributor.authorAmeigeiras, Beatriz
dc.contributor.authorBriz, Veronica
dc.contributor.authorCasciato, Paola
dc.contributor.authorPreciado, María Victoria
dc.contributor.authorValva, Pamela
dc.contributor.authorFernandez-Rodriguez, Amanda
dc.contributor.funderConferencia de Rectores de las Universidades Españolas
dc.contributor.funderConsejo Superior de Investigaciones Científicas (España)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderRed de Investigación Cooperativa en Investigación en Sida (España)es_ES
dc.contributor.funderCentro de Investigación Biomédica en Red - CIBERINFEC (Enfermedades Infecciosas)
dc.contributor.funderAgencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación (Argentina)es_ES
dc.contributor.funderConsejo Nacional de Investigaciones Científicas y Técnicas (Argentina)es_ES
dc.date.accessioned2023-09-29T09:55:20Z
dc.date.available2023-09-29T09:55:20Z
dc.date.issued2023-09-14
dc.description.abstractHepatitis C virus (HCV) coinfection with human immunodeficiency virus (HIV) has a detrimental impact on disease progression. Increasing evidence points to extracellular vesicles (EVs) as important players of the host-viral cross-talk. The microRNAs (miRNAs), as essential components of EVs cargo, are key regulators of normal cellular processes and also promote viral replication, viral pathogenesis, and disease progression. We aimed to characterize the plasma-derived EVs miRNA signature of chronic HCV infected and HIV coinfected patients to unravel the molecular mechanisms of coinfection. EVs were purified and characterized from 50 plasma samples (21 HCV mono- and 29 HCV/HIV co-infected). EV-derived small RNAs were isolated and analyzed by massive sequencing. Known and de novo miRNAs were identified with miRDeep2. Significant differentially expressed (SDE) miRNA identification was performed with generalized linear models and their putative dysregulated biological pathways were evaluated. Study groups were similar for most clinical and epidemiological characteristics. No differences were observed in EVs size or concentration between groups. Therefore, HCV/HIV co-infection condition did not affect the concentration or size of EVs but produced a disturbance in plasma-derived EVs miRNA cargo. Thus, a total of 149 miRNAs were identified (143 known and 6 de novo) leading to 37 SDE miRNAs of which 15 were upregulated and 22 downregulated in HCV/HIV co-infected patients. SDE miRNAs regulate genes involved in inflammation, fibrosis, and cancer, modulating different biological pathways related to HCV and HIV pathogenesis. These findings may help to develop new generation biomarkers and treatment strategies, in addition to elucidate the mechanisms underlying virus-host interaction. KEY MESSAGES: HCV and HCV/HIV displayed similar plasma-EV size and concentration. EVs- derived miRNA profile was characterized by NGS. 37 SDE miRNAs between HCV and HCV/HIV were observed. SDE miRNAs regulate genes involved in inflammation, fibrosis and cancer.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipOpen Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work has been supported by grants from (1) Institute of Health Carlos III, Spain [PI18CIII/00020/ to AFR], (2) PID2021–126781OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”, (3) The SPANISH AIDS Research Network RD16CIII/0002/0002 - ISCIII – FEDER, (4) Centro de Investigación en Red en Enfermedades Infecciosas (CIBERINFEC) CB21/13/00044, (5) the National Agency for Scientific and Technology Promotion (ANPCyT) (PICT 2017 Nº713), and (6) the National Research Council (CONICET, PIP 2021-2023). V.C. received funding form the Asociación Universitaria Iberoamericana de Postgrado (AUIP) for the Academic Mobility Scholarship Program. P.V., E.D.M., and M.V.P. are members of the CONICET-Research Career Program. V.C. is a fellow from ANPCyT. The funder’s had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.es_ES
dc.format.number11
dc.format.page1409-1420
dc.format.volume101
dc.identifier.citationJ Mol Med (Berl). 2023 Nov;101(11):1409-1420.es_ES
dc.identifier.doi10.1007/s00109-023-02367-8es_ES
dc.identifier.e-issn1432-1440es_ES
dc.identifier.journalJournal of molecular medicine (Berlin, Germany)es_ES
dc.identifier.pubmedID37704856es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16533
dc.language.isoenges_ES
dc.publisherSpringer
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2021-126781OB-I00es_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/Subprograma Estatal de Generación de Conocimiento/PI18-ISCIII Modalidad Proyectos de Investigacion en Salud Intramurales. (2018)/PI18CIII/00020es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/RD16CIII/0002/0002es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/CB21/13/00044es_ES
dc.relation.publisherversionhttps://doi.org/10.1007/s00109-023-02367-8es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiología::Unidades Comunes Científico-Técnicas (UCCT)es_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectChronic hepatitis C infectiones_ES
dc.subjectHCV/HIV coinfectiones_ES
dc.subjectmiRNAses_ES
dc.subjectPathogenesises_ES
dc.subjectLiver diseaseses_ES
dc.subjectExtracellular vesicleses_ES
dc.titleMicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infectedes_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication7dfa2699-8d26-42af-a510-b0ef10e0b9cc
relation.isAuthorOfPublication4912bd28-c8c7-487c-8b80-d03640b99ea4
relation.isAuthorOfPublication9801eb3d-9196-4528-9021-47d82b2910e4
relation.isAuthorOfPublication727b9535-a250-4e80-969f-c5d33f92246d
relation.isAuthorOfPublication6a32a4a3-2d81-43c5-8295-48346efbf498
relation.isAuthorOfPublication.latestForDiscovery7dfa2699-8d26-42af-a510-b0ef10e0b9cc
relation.isFunderOfPublication16f24b1c-4d1f-42f2-9b40-056614f5a6c9
relation.isFunderOfPublication811243fc-9fda-46b1-b312-9259d8c570f6
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublication0b5a6d3a-4d4d-4346-9bcc-9359bbe13e72
relation.isFunderOfPublication.latestForDiscovery16f24b1c-4d1f-42f2-9b40-056614f5a6c9
relation.isPublisherOfPublication8d558850-2ef2-4d1e-b0e1-4e5591ab6288
relation.isPublisherOfPublication.latestForDiscovery8d558850-2ef2-4d1e-b0e1-4e5591ab6288

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
MicroRNA_SignatureExtracellularVesicles_2023.pdf
Size:
2.68 MB
Format:
Adobe Portable Document Format
Description:
Articulo
Loading...
Thumbnail Image
Name:
Supplementary_MicroRNA_SignatureExtracellularVesicles_2023.pdf
Size:
909.69 KB
Format:
Adobe Portable Document Format
Description:
Supplementary material